+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5441907
  • Report
  • September 2021
  • Region: Global
  • 145 pages
  • IMARC Group

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Eli Lilly and Company
  • MORE
The global protein therapeutics market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.

Protein therapeutics refers to artificially synthesized protein-based medicines. They are fast-acting, potent medicines that deliver small protein molecules to the body in a specific amount. They usually consist of recombinant forms of naturally occurring proteins, such as monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormones (HGH) and follicle-stimulating hormones. They aid in treating chronic medical ailments, such as cancer, diabetes, neurodegenerative disorders and immunological, hematological, hormonal and genetic disorders. Various combination therapy drugs are also used with protein therapeutics that can be inhaled, injected or orally administered.

Global Protein Therapeutics Market Trends and Drivers


The increasing prevalence of chronic medical ailments is one of the key factors driving the growth of the protein therapeutics market. In line with this, the rising awareness among the masses regarding the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, are contributing to the market growth. Monoclonal antibodies are being widely researched and used for the treatment of various viral and bacterial diseases and pharmaceutical companies are using protein therapeutics for drug discovery and development. The sudden outbreak of the coronavirus disease (COVID-19) is further providing growth opportunities to market players. For instance, Molecular Partners AG, a Switzerland-based clinical stage biotechnology company, is developing a new class of protein therapeutics, called DARPin®, to inhibit the proliferation of the virus.

The development of novel recombinant proteins, peptides, antibody-based drugs and plasma proteins is acting as other-growth inducing factors. These protein therapeutics are extensively used in replacement therapies to treat genetic and autoimmune disorders, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. Other factors, including extensive research and development (R&D) activities in the field of protein engineering, along with significant improvements in the healthcare infrastructure, are expected to drive the market further.

Key Market Segmentation


The analyst provides an analysis of the key trends in each sub-segment of the global protein therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on region, product, therapy area and function.

Breakup by Product

  • Monoclonal Antibodies (mAbs)
  • Human Insulin
  • Erythropoietin
  • Clotting Factors
  • Fusion Protein
  • Others

Breakup by Therapy Area

  • Metabolic Disorders
  • Immunological Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

Breakup by Function

  • Enzymatic and Regulatory Activity
  • Special Targeting Activity
  • Vaccines
  • Protein Diagnostics

Breakup by Region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The report has also analysed the competitive landscape of the market with some of the key players being Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc.

Key Questions Answered in This Report

  • How has the global protein therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global protein therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the function?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global protein therapeutics market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Eli Lilly and Company
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Protein Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Monoclonal Antibodies (mAbs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Human Insulin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Erythropoietin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Clotting Factors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Fusion Protein
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast

7 Market Breakup by Therapy Area
7.1 Metabolic Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunological Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hematological Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cancer
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Hormonal Disorders
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Genetic Disorders
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast

8 Market Breakup by Function
8.1 Enzymatic and Regulatory Activity
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Special Targeting Activity
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Vaccines
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Protein Diagnostics
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abbott Laboratories
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Abbvie Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Baxter International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Biogen Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Csl Behring L.L.C. (CSL Limited)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Eli Lilly and Company
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Johnson & Johnson
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck & Co. Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Novo Nordisk A/S (Novo Holdings A/S)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Pfizer Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

List of Figures
Figure 1: Global: Protein Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Protein Therapeutics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Protein Therapeutics Market: Breakup by Product (in %), 2020
Figure 4: Global: Protein Therapeutics Market: Breakup by Therapy Area (in %), 2020
Figure 5: Global: Protein Therapeutics Market: Breakup by Function (in %), 2020
Figure 6: Global: Protein Therapeutics Market: Breakup by Region (in %), 2020
Figure 7: Global: Protein Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Protein Therapeutics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Protein Therapeutics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Protein Therapeutics (Human Insulin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Protein Therapeutics (Human Insulin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Protein Therapeutics (Erythropoietin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Protein Therapeutics (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Protein Therapeutics (Clotting Factors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Protein Therapeutics (Clotting Factors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Protein Therapeutics (Fusion Protein) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Protein Therapeutics (Fusion Protein) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Protein Therapeutics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Protein Therapeutics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Protein Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Protein Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Protein Therapeutics (Immunological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Protein Therapeutics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Protein Therapeutics (Hematological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Protein Therapeutics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Protein Therapeutics (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Protein Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Protein Therapeutics (Hormonal Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Protein Therapeutics (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Protein Therapeutics (Genetic Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Protein Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Protein Therapeutics (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Protein Therapeutics (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Protein Therapeutics (Special Targeting Activity) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Protein Therapeutics (Special Targeting Activity) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Protein Therapeutics (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Protein Therapeutics (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: Protein Therapeutics (Protein Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Global: Protein Therapeutics (Protein Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: North America: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: North America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: United States: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: United States: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Canada: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Canada: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Asia Pacific: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Asia Pacific: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: China: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: China: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Japan: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Japan: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: India: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: India: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: South Korea: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: South Korea: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Australia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Australia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Indonesia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Indonesia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Europe: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Europe: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Germany: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Germany: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: France: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: France: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: United Kingdom: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: United Kingdom: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Italy: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Italy: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Spain: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Spain: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Russia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Russia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Latin America: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Latin America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Brazil: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Brazil: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Mexico: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Mexico: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Middle East and Africa: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 89: Middle East and Africa: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Global: Protein Therapeutics Industry: SWOT Analysis
Figure 91: Global: Protein Therapeutics Industry: Value Chain Analysis
Figure 92: Global: Protein Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables
Table 1: Global: Protein Therapeutics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Protein Therapeutics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Protein Therapeutics Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: Global: Protein Therapeutics Market Forecast: Breakup by Function (in Million US$), 2021-2026
Table 5: Global: Protein Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Protein Therapeutics Market Structure
Table 7: Global: Protein Therapeutics Market: Key Players
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • Abbott Laboratories
  • Abbvie Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Csl Behring L.L.C. (CSL Limited)
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk A/S (Novo Holdings A/S)
  • Pfizer Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll